VERTEX PHARMACEUTICALS INC

The current price of VX1 is 363.619 CHF — it has decreased by 0.39% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BX exchange VERTEX PHARMACEUTICALS INC stocks are traded under the ticker VX1.

VERTEX PHARMACEUTICALS INC is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.

VX1 stock is 0.39% volatile and has beta coefficient of 0.89. Check out the list of the most volatile stocks — is VERTEX PHARMACEUTICALS INC there?

VX1 earnings for the last quarter are 3.74 CHF per share, whereas the estimation was 3.60 CHF resulting in a 3.72% surprise. The estimated earnings for the next quarter are 3.42 CHF per share. See more details about VERTEX PHARMACEUTICALS INC earnings.

VERTEX PHARMACEUTICALS INC revenue for the last quarter amounts to ‪2.27 B‬ CHF despite the estimated figure of ‪2.29 B‬ CHF. In the next quarter revenue is expected to reach ‪2.12 B‬ CHF.

Yes, you can track VERTEX PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.

VX1 stock has fallen by 0.39% compared to the previous week, the month change is a 0.49% rise, over the last year VERTEX PHARMACEUTICALS INC has showed a 22.31% increase.

Today VERTEX PHARMACEUTICALS INC has the market capitalization of ‪94.31 B‬, it has decreased by 0.50% over the last week.

No, VX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, VX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERTEX PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.

VX1 reached its all-time high on Jan 24, 2024 with the price of 379.318 CHF, and its all-time low was 170.796 CHF and was reached on Oct 22, 2021.
See other stocks reaching their highest and lowest prices.

As of Apr 23, 2024, the company has ‪5.40 K‬ employees. See our rating of the largest employees — is VERTEX PHARMACEUTICALS INC on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VERTEX PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VERTEX PHARMACEUTICALS INC stock shows the buy signal. See more of VERTEX PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on VERTEX PHARMACEUTICALS INC future price: according to them, VX1 price has a max estimate of 522.82 CHF and a min estimate of 296.02 CHF. Read a more detailed VERTEX PHARMACEUTICALS INC forecast: see what analysts think of VERTEX PHARMACEUTICALS INC and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VERTEX PHARMACEUTICALS INC EBITDA is ‪3.33 B‬ CHF, and current EBITDA margin is 45.32%. See more stats in VERTEX PHARMACEUTICALS INC financial statements.